Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Apr-24 8:05 PM View:  | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 18-Apr-24 | Sale | 1,234 | $25.11 | $30,985.70 | (3%) 38.4K to 37.16K | |
| 02-Apr-24 8:29 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 01-Apr-24 | Sale (Planned) | 25,000 | $28.31 | $707,750.00 | (4%) 574.59K to 549.59K | |
| 11-Mar-24 8:00 PM View: | Selick Harold E Director | Protagonist Therapeutics, Inc (PTGX) | 07-Mar-24 | Option Exercise | 6,490 | $1.89 | $12,266.10 | 30% 21.51K to 28.0K | |
| 01-Mar-24 8:45 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Option Sale | 2,061 | $32.24 | $66,441.20 | (4%) 52.65K to 50.58K | |
| 01-Mar-24 8:45 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Option Exercise | 12,000 | $12.17 | $146,040.00 | 30% 40.65K to 52.65K | |
| 01-Mar-24 8:45 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Sale | 12,187 | $32.24 | $392,877.00 | (24%) 50.58K to 38.4K | |
| 01-Mar-24 8:45 PM View: | Waddill William D. Director | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Option Exercise | 12,975 | $6.09 | $79,017.80 | 108% 12.0K to 24.98K | |
| 01-Mar-24 8:46 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Market Sale (Planned) | 30,000 | $31.62 | $948,600.00 | (5%) 604.59K to 574.59K | (9%) |
| 01-Mar-24 8:45 PM View: | Waddill William D. Director | Protagonist Therapeutics, Inc (PTGX) | 01-Mar-24 | Planned Option Sale | 12,975 | $31.34 | $406,636.00 | (52%) 24.98K to 12.0K | |
| 01-Mar-24 8:45 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 29-Feb-24 | Market Option Sale | 9,939 | $30.69 | $305,048.00 | (20%) 50.58K to 40.65K | (13%) |
| 28-Feb-24 8:02 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 26-Feb-24 | Payment of Exercise | 10,915 | $29.53 | $322,320.00 | (2%) 615.5K to 604.59K | |
| 28-Feb-24 8:00 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 26-Feb-24 | Payment of Exercise | 4,282 | $29.53 | $126,447.00 | (2%) 187.57K to 183.28K | |
| 20-Feb-24 8:00 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 15-Feb-24 | Payment of Exercise | 3,717 | $28.23 | $104,931.00 | (< 1%) 619.22K to 615.5K | |
| 18-Jan-24 8:00 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 16-Jan-24 | Payment of Exercise | 1,452 | $24.63 | $35,762.80 | (3%) 52.04K to 50.58K | |
| 18-Jan-24 8:00 PM View: | Molina Arturo Md Chief Medical Officer | Protagonist Therapeutics, Inc (PTGX) | 16-Jan-24 | Payment of Exercise | 427 | $24.63 | $10,517.00 | (< 1%) 48.78K to 48.35K | |
| 11-Jan-24 8:00 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 09-Jan-24 | Planned Option Sale | 5,000 | $25.00 | $125,000.00 | (3%) 192.57K to 187.57K | |
| 11-Jan-24 8:00 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 09-Jan-24 | Option Exercise | 5,000 | $7.38 | $36,900.00 | 3% 187.57K to 192.57K | |
| 04-Jan-24 8:09 PM View: | Molina Arturo Md Chief Medical Officer | Protagonist Therapeutics, Inc (PTGX) | 02-Jan-24 | Grant | 26,250 | -- | -- | 117% 22.53K to 48.78K | |
| 04-Jan-24 8:11 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 02-Jan-24 | Grant | 84,875 | -- | -- | 16% 534.35K to 619.22K | |
| 04-Jan-24 8:15 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 02-Jan-24 | Grant | 19,250 | -- | -- | 11% 168.32K to 187.57K | |
| 04-Jan-24 8:07 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 02-Jan-24 | Grant | 21,000 | -- | -- | 68% 31.04K to 52.04K | |
| 15-Dec-23 4:30 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 13-Dec-23 | Sale (Planned) | 75,000 | $20.08 | $1,506,000.00 | (12%) 609.35K to 534.35K | |
| 04-Jan-24 8:09 PM View: | Molina Arturo Md Chief Medical Officer | Protagonist Therapeutics, Inc (PTGX) | 15-Nov-23 | Sale | 1,848 | $16.24 | $30,011.50 | (8%) 24.38K to 22.53K | |
| 23-Oct-23 4:31 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 19-Oct-23 | Option Exercise | 20,000 | $7.38 | $147,600.00 | 13% 148.32K to 168.32K | |
| 19-Oct-23 4:55 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 18-Oct-23 | Option Exercise | 6,000 | $4.21 | $25,260.00 | < 1% 603.35K to 609.35K | |
| 02-Jun-23 7:48 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 31-May-23 | Grant | 12,000 | -- | -- | 52% 23.19K to 35.19K | |
| 02-Jun-23 7:50 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 31-May-23 | Payment of Exercise | 12,165 | $26.07 | $317,142.00 | (2%) 615.11K to 602.95K | |
| 02-Jun-23 7:51 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 31-May-23 | Grant | 12,000 | -- | -- | 9% 140.19K to 152.19K | |
| 02-Jun-23 7:48 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 31-May-23 | Payment of Exercise | 4,150 | $26.07 | $108,190.00 | (12%) 35.19K to 31.04K | |
| 02-Jun-23 7:51 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 31-May-23 | Payment of Exercise | 4,150 | $26.07 | $108,190.00 | (3%) 152.19K to 148.04K | |
| 02-Jun-23 7:50 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 31-May-23 | Grant | 30,000 | -- | -- | 5% 585.11K to 615.11K | |
| 19-Apr-23 4:28 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 18-Apr-23 | Payment of Exercise | 1,189 | $23.21 | $27,596.70 | (5%) 24.38K to 23.19K | |
| 11-Apr-23 7:18 PM View: | Selick Harold E Director | Protagonist Therapeutics, Inc (PTGX) | 10-Apr-23 | Option Exercise | 6,196 | $0.87 | $5,390.52 | 40% 15.31K to 21.51K | |
| 02-Jun-23 7:50 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 22-Feb-23 | Gift | 10,000 | -- | -- | (2%) 593.45K to 583.45K | |
| 18-Jan-23 7:56 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 16-Jan-23 | Grant | 20,625 | -- | -- | 18% 117.56K to 138.19K | |
| 18-Jan-23 7:53 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 16-Jan-23 | Grant | 10,625 | -- | -- | 77% 13.75K to 24.38K | |
| 18-Jan-23 7:51 PM View: | Molina Arturo Md Chief Medical Officer | Protagonist Therapeutics, Inc (PTGX) | 16-Jan-23 | Grant | 3,125 | -- | -- | 15% 21.25K to 24.38K | |
| 18-Jan-23 7:48 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 28-Dec-22 | Gift | 3,116 | -- | -- | (< 1%) 601.21K to 598.1K | |
| 17-Nov-22 6:24 PM View: | Liu David Y Chief R&D Strategy Officer | Protagonist Therapeutics, Inc (PTGX) | 16-Nov-22 | Option Exercise | 100,479 | $2.31 | $231,802.00 | 150% 67.11K to 167.59K | |
| 17-Nov-22 6:22 PM View: | Molina Arturo Md Chief Medical Officer | Protagonist Therapeutics, Inc (PTGX) | 15-Nov-22 | Grant | 21,250 | -- | -- | 100% 0 to 21.25K | |
| 24-Aug-22 6:15 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 23-Aug-22 | Option Exercise | 20,000 | $4.21 | $84,200.00 | 3% 584.05K to 604.05K | |
| 04-May-22 8:33 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 04-May-22 | Option Exercise | 15,742 | $4.21 | $66,273.80 | 3% 568.31K to 584.05K | |
| 18-Jan-23 7:48 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 04-May-22 | Gift | 3,000 | -- | -- | (< 1%) 584.05K to 581.05K | |
| 04-May-22 8:41 PM View: | Waddill William D. Director | Protagonist Therapeutics, Inc (PTGX) | 03-May-22 | Option Exercise | 12,000 | $8.59 | $103,080.00 | 100% 0 to 12.0K | |
| 26-Apr-22 9:34 PM View: | Patel Dinesh V Ph D President and CEO Director | Protagonist Therapeutics, Inc (PTGX) | 26-Apr-22 | Option Exercise | 30,000 | $4.21 | $126,300.00 | 6% 538.31K to 568.31K | |
| 26-Apr-22 9:42 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 26-Apr-22 | Option Exercise | 40,000 | $7.38 | $295,200.00 | 52% 77.56K to 117.56K | |
| 19-Apr-22 7:48 PM View: | Ali Asif Chief Financial Officer | Protagonist Therapeutics, Inc (PTGX) | 18-Apr-22 | Grant | 13,750 | -- | -- | 100% 0 to 13.75K | |
| 14-Apr-22 8:09 PM View: | Patel Dinesh V Ph D President and CEO Director 10% Owner | Protagonist Therapeutics, Inc (PTGX) | 14-Apr-22 | Option Exercise | 34,087 | $1.89 | $64,424.40 | 7% 503.76K to 537.85K | |
| 02-Mar-22 8:38 PM View: | Liu David Y Chief Scientific Officer | Protagonist Therapeutics, Inc (PTGX) | 28-Feb-22 | Payment of Exercise | 2,119 | $24.28 | $51,449.30 | (3%) 68.66K to 66.54K | |
| 02-Mar-22 8:40 PM View: | Gupta Suneel Chief Development Officer | Protagonist Therapeutics, Inc (PTGX) | 28-Feb-22 | Payment of Exercise | 649 | $24.28 | $15,757.70 | (< 1%) 77.66K to 77.01K |
